Who are Tenaya Therapeutics's investors?

Tenaya Therapeutics's investors include GV (Google Ventures), RA Capital, The Column Group, venBio Partners.

Where is Tenaya Therapeutics headquartered?

Tenaya Therapeutics is headquartered in South San Francisco, US.

Tenaya Therapeutics

NASDAQ: TNYA

South San Francisco, US · Founded 2016 · Incorporated in Delaware · 93 employees on LinkedIn · 4 known investors

Find your way into Tenaya Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Tenaya Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Tenaya Therapeutics is a biotechnology company focused on discovering and developing therapies for heart disease. This page is a board/leadership team bio page.

Biotech Healthtech

Founders & leadership

Tenaya Therapeutics was founded in 2016 by Deepak Srivastava, M.D., Eric Olson, Ph.D., Bruce R. Conklin, M.D., Sheng Ding, Ph.D., and Saptarsi Haldar, M.D..

Deepak Srivastava, M.D.Co-Founder and Chair, Scientific Advisory Board

Eric Olson, Ph.D.Scientific Founder

Bruce R. Conklin, M.D.Co-FounderBruce R. Conklin is a physician-scientist and investigator at Gladstone Institutes, as well as a professor of medicine, ophthalmology, and pharmacology at UCSF, where he also serves as deputy director of the Innovative Genomics Institute. He specializes in stem cell research and genome engineering.

Sheng Ding, Ph.D.Scientific Founder

Saptarsi Haldar, M.D.Scientific Co-Founder2016–2018Saptarsi Haldar is a physician and cardiologist with experience spanning academic medicine, biotech, and pharmaceutical development, with expertise in drug discovery, translational research, and clinical practice.

Eric Hyllengren Chief Financial OfficerHe previously served as CFO and EVP at Zura Bio and as CFO and COO at Atara Biotherapeutics, where he oversaw over $500 million in public financings, and spent fifteen years in finance, investor relations, and business development roles at Amgen. He holds a B.B.A. in finance and Russian from the University of Notre Dame and an M.B.A. in finance from Northwestern University's Kellogg School of Management.

Faraz Ali, MBAChief Executive Officer

Investors · 4

GV (Google Ventures)listed by GV (Google Ventures)Mountain View · $250K – $50M

How we know: GV (Google Ventures)'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · Not right? Tell us

The Column Grouplisted by The Column GroupSan Francisco · $30M

How we know: The Column Group's portfolio page · the S-1 prospectus · Not right? Tell us

venBio Partnerslisted by venBio PartnersSan Francisco

How we know: venBio Partners's portfolio page · Not right? Tell us

Valuation · disclosed

Disclosed events

$589.9Mvaluation at IPOJul 2021 · $15.00/share · 424B4

filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Related companies · 2

AskBioAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.

NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.

Companies working in the same space as Tenaya Therapeutics.

Frequently asked questions

What does Tenaya Therapeutics do?: Tenaya Therapeutics is a biotechnology company focused on discovering and developing therapies for heart disease. This page is a board/leadership team bio page.
Who founded Tenaya Therapeutics?: Tenaya Therapeutics was founded by Deepak Srivastava, M.D., Eric Olson, Ph.D., Bruce R. Conklin, M.D., Sheng Ding, Ph.D., Saptarsi Haldar, M.D. in 2016.
Who are Tenaya Therapeutics's investors?: Tenaya Therapeutics's investors include GV (Google Ventures), RA Capital, The Column Group, venBio Partners.
Where is Tenaya Therapeutics headquartered?: Tenaya Therapeutics is headquartered in South San Francisco, US.